Notes to Unaudited Financial Statements
The inputs and assumptions used to estimate the fair value of share-based payment awards represent management’s best estimates and involve inherent uncertainties and the application of management’s judgment. As a result, if factors change and management uses different inputs and assumptions, the Company’s share-based compensation expense could be materially different for future awards.
For the six months ended June 30, 2021 and 2020, the grant-date fair value of stock options was estimated at the time of grant using the following weighted-average inputs and assumptions in the Black-Scholes option pricing model:
| | | | | | | | |
| |
| |
| | | | | | |
Weighted-average expected volatility | | | 52.08 | % | | | 69.88 | % |
Weighted-average expected term (years) | | | 6.23 | | | | 6.23 | |
Weighted-average expected risk-free interest rate | | | 0.70 | % | | | 0.74 | % |
| | | 0.00 | % | | | 0.00 | % |
| | | | | | | | |
Weighted-average fair value of options granted | | $ | 20.95 | | | $ | 8.42 | |
On September 25, 2020, the Company completed its IPO in which the Company issued and sold 3,047,500 shares of its common stock at a public offering price of $22 per share. Upon the closing of the IPO, all outstanding shares of the Company’s preferred stock converted into shares of common stock, consisting of (i) 162,340 outstanding shares of Series
A-1
convertible preferred stock converting into 324,680 aggregate shares of common stock, (ii) 152,253 outstanding shares of Series
A-2
convertible preferred stock converting into 304,506 aggregate shares of common stock, and (iii) 383,142 outstanding shares of Series
B-1
convertible preferred stock converting into 766,284 aggregate shares of common stock.
As of June 30, 2021 and December 31, 2020, the Company is authorized to issue 5,000,000 shares of preferred stock, par value $0.001 per share, and there were 0 shares of preferred stock issued or outstanding.
Series
A-1
and
A-2
Preferred Stock
Effective November 19, 2018, the
Company executed a capital transaction of $
25,000,000
with a private investor, with $
15,000,000
funded at the closing date and an additional $
10,000,000
to be funded one year following the execution. The additional tranche was determined to be embedded in the initial agreement and not subject to bifurcation accounting. The investing entity received Series
A-1
preferred stock, carrying certain standard protective provisions.
In conjunction with this equity infusion, in November and December 2018, the Company further sold to existing stockholders an additional $7,000,000 of shares of Series
A-1
and
A-2
preferred stock.
All shares of Series
A-1
and
A-2
preferred stock issued were convertible into common stock at any time at the option of the holder, or mandatorily convertible into common stock upon the event of an initial public offering. The Series
A-1
and
A-2
preferred stock were redeemable upon the occurrence of a deemed liquidation event. The Company determined that this redemption feature requires classification of both Series
A-1
and
A-2
preferred stock as mezzanine equity in our balance sheet as of December 31, 2019.
Shares of Series
A-2
preferred stock were issued at a 20% discount, based on preexisting terms in a line of credit agreement with East. As a result, the $673,133 was recorded as a reduction to additional
in 2018 and was considered a deemed dividend increasing the net loss attributable to common stockholders.
On November 18, 2019, the Company negotiated the repurchase of 609,013 shares of Series
A-1
preferred stock from a private investor for $7,500,000, or $12.32 per share, and the termination of the private investor’s commitment to fund an additional $10,000,000 in November 2019. At the time of repurchase, the carrying value of the shares of Series
A-1
preferred stock outstanding on the balance sheet was $14,999,901, or a value of $24.63 per share. The favorable rate at which the shares were able to be negotiated resulted in a deemed contribution of $7,448,879 which was included in net loss available to common stockholders.
Series
B-1
and
B-2
Preferred Stock
Effective April 13, 2020, the Company completed a private placement to DMV for 383,142 shares of its Series
B-1
Preferred Stock for total proceeds of $10,000,006, or $26.10 per share. The shares of Series
B-1
Preferred Stock issued were convertible into common stock at any time at the option of the holder, or mandatorily convertible into common stock upon the event of an initial public offering. The Series
B-1
Preferred Stock were redeemable upon the occurrence of a deemed liquidation event. The Company determined that
this redemption feature required
classification of the Series
B-1
Preferred Stock as mezzanine equity in our balance sheet.